Skip to : [Content] [Navigation]
 

 

July 2001
Medical Device & Diagnostic Industry
Selected Contents



EDITOR'S PAGE:
Where Have All The Dot-Coms Gone?


Perhaps the Internet is just too good an idea. When something that spectacular, that promising, comes along, it's very difficult not to become irrational.



COVER STORY:
Industry and the Internet: A Second Look

MD&DI's special Internet section examines how medical device manufacturers are coping with—and profiting from—the changing landscape of the Web.

Revisiting Healthcare Markets on the Internet: Dot-Com or Dot-Gone?
Cliff Henke

Despite the disappearance of many of the Web-based medical exchanges in the past year, surviving medical technology dot-coms continue to make progress, quietly fulfilling their promises.

FDA's Regulation of Internet Promotion and Advertising
Jeffrey K. Shapiro and Jonathan S. Kahan

Medical device manufacturers must closely monitor the content of their Web sites and related links to avoid being reprimanded by FDA for product adulteration or misbranding.

Collaborative Commerce for the Global Economy
Michael J. Carroll and Christopher Williams

To compete in the new economy, medical device manufacturers must take advantage of the Internet's instant communications and collaborative platforms throughout the supply chain.

Satisfying QSR Requirements with Collaborative Production Management Systems
Steven A. Vogel

A technology based on the Internet and intranets can automate the tasks required for regulatory compliance.

Creating Electronic Catalogs for Greater Customer Interaction and Product Exposure
Lynda Brooks

With the proper planning, medical device companies can publish product catalogs in a variety of media from one master database.


Incorporating the New HIPAA Privacy Rules into Medical Device Trials
Nancy J. Stark and Erica Heath

Medical device manufacturers who sponsor clinical trials have reason for concern when it comes to the need for a fast, smooth trial process.


R&D DIGEST
A review of cutting-edge technologies and medical innovations


THIS MONTH: Making stronger plastics * Miniprobe could reduce biopsy use * Micro-organs restore liver function * Noble gases aid lung-disease detection



WASHINGTON WRAP-UP:
FDA Reverses Stance on Firm's News Release

James G. Dickinson

A medical device company's stock was sent reeling after FDA reacted adversely—and publicly—to its press release. How much attention does the agency pay to Wall Street?


MEDICAL PLASTICS & BIOMATERIALS:
Enhancing Device Development through Early Supplier Involvement
Todd Owens

Contract suppliers who get in on the development process early will be the most valuable and reap the largest rewards.


Bulletin Board

Larger, machinable ceramic plates available.
Compounds are flexible after curing.
Company divides plants into subgroups, and more!